Companies › Qvanteq

Qvanteq

Healthcare 📍 Zürich, Switzerland 👥 11-50 employees 📅 Founded 2009

Qvanteq develops novel stent technologies to address and overcome the clinically adverse effects of today’s available coronary artery stents. A coronary stent is a small (metal) mesh tube which is being implanted into coronary arteries to prevent heart attacks. Qvanteq is ISO 13485 certified. It is a spin-off company

📊 Company Overview

Sector
Healthcare
Country
Switzerland
Employees
11-50
Founded
2009
Cloud
Unknown
Email
Google Workspace

☁️ Cloud Infrastructure

🔒 Subscribers only Cloud Provider
WorkspaceGoogle Workspace
CDN🔒 Subscribers only

Detected via DNS records and HTTP response headers as of 2026-06-13.

💰 Estimated Cloud Spend

$108K $270K / year across cloud providers

🛠 Tech Stack & Marketing

Ad Platforms🔒 Subscribers only
Analytics & CRM🔒 Subscribers only
CMS / PlatformWordPress
Frontend Stack🔒 Subscribers only

Detected from Qvanteq's public homepage as of 2026-06-13.

🔍 Compare with Similar Companies

Same sector (Healthcare), similar size

Data detected 2026-06-13 · Methodology · Suggest a correction